Earlier Use of Long-Acting Injectable Paliperidone Palmitate Once-Monthly versus Oral Antipsychotics in Patients with Schizophrenia: An Integrated Patient-Level Meta Analysis of the PROSIPAL and PRIDE Studies [Corrigendum]

Sajatovic M, Doring M, Lopena OJ, et al. Neuropsychiatr Dis Treat. 2024;20:2227—2235. The authors have advised that there is a data error in Table 2 on page 2233. Under 0-3 Years n = 516, PP1M n = 253 column, Injection site pain row, the data “2 (9.5%)” should read “24 (9.5%)”. The correct Table 2 is as follows. Table 2 Incidence of Treatment-Emergent Adverse Events The authors apologize for this oversight.